Insider trades › Bristol Myers Squibb › Cristian Massacesi

Cristian Massacesi: Bristol Myers Squibb stock transactions

Cristian Massacesi (EVP,Chief Med Offr,Head of Dev at Bristol Myers Squibb) reported 3 transactions in BMY stock on SEC Form 4 over the last 120 days. Name as filed with the SEC: Massacesi Cristian.

$403Kopen-market sales (6,249 shares)
$0open-market purchases (0 shares)
2026-09-09most recent transaction

Transactions

Date Transaction Shares Price Value Filing
Sep 9, 2026 Open-market sale 6,249 $64.57 $403K Form 4 ↗
Aug 1, 2026 Option or RSU exercise 51,172 — — Form 4 ↗
Aug 1, 2026 Shares withheld for tax 26,175 $65.31 — Form 4 ↗

Source: SEC EDGAR Form 4 filings; each row links to the filing. Sales marked "10b5-1 plan" were reported as made under a pre-arranged trading plan. Insider trades are reported facts, not recommendations. Not investment advice.